Literature DB >> 22395239

Brain natriuretic peptide in apical ballooning syndrome (Takotsubo/stress cardiomyopathy): comparison with acute myocardial infarction.

Kamran A Ahmed1, Malini Madhavan, Abhiram Prasad.   

Abstract

OBJECTIVES: Apical ballooning syndrome (ABS) is a transient cause of ventricular dysfunction. The aim of this study was to determine the clinical and hemodynamic correlates of brain natriuretic peptide (BNP) levels in ABS and compare the biomarker profiles in ABS with acute myocardial infarction controls.
METHODS: Fifty-seven prospectively diagnosed patients with ABS whose BNP and troponin T level measurements were available were included. Fifty patients with ST-elevation myocardial infarction (STEMI) and 25 individuals with non-ST-elevation myocardial infarction (NSTEMI) were included as matched controls.
RESULTS: In the ABS cohort, the BNP levels were higher in patients older than 65 years compared with younger individuals: 767 (269, 951) versus 340 (131, 904.5), P=0.019. There were no significant correlations between BNP levels and hemodynamic parameters such as left ventricular ejection fraction and end diastolic pressure. There were no correlations between BNP and peak troponin T (r=0.03, P=0.8). BNP levels were significantly higher in ABS patients when compared with the STEMI and NSTEMI controls. The BNP to peak troponin T ratio was significantly higher in ABS compared with the STEMI controls 1089.4 (446.7, 3334.8) versus 97.4 (17.9, 264.7), P=0.04.
CONCLUSION: BNP elevation is almost universal in ABS. Cardiac hemodynamic indices do not correlate with BNP levels. The magnitude of BNP elevation is higher in ABS compared with STEMI and NSTEMI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22395239     DOI: 10.1097/MCA.0b013e3283526a57

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  9 in total

1.  Carbohydrate-antigen-125 levels predict hospital stay duration and adverse events at long-term follow-up in Takotsubo cardiomyopathy.

Authors:  Francesco Santoro; Armando Ferraretti; Francesco Musaico; Luigi Di Martino; Nicola Tarantino; Riccardo Ieva; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Intern Emerg Med       Date:  2016-02-01       Impact factor: 3.397

2.  Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.

Authors:  Thomas Stiermaier; Francesco Santoro; Tobias Graf; Francesca Guastafierro; Nicola Tarantino; Luisa De Gennaro; Pasquale Caldarola; Matteo Di Biase; Holger Thiele; Natale D Brunetti; Christian Möller; Ingo Eitel
Journal:  Clin Res Cardiol       Date:  2018-04-19       Impact factor: 5.460

3.  Author's reply.

Authors:  Ankavipar Saprungruang; Aichai Khongphatthanayothin
Journal:  J Cardiol Cases       Date:  2019-11-06

4.  A Case Report of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Acute Pancreatitis Induced Takotsubo Cardiomyopathy (TCM) in a Patient With Gallstones Induced Acute Pancreatitis and Cholangitis.

Authors:  Zahid Khan
Journal:  Cureus       Date:  2022-05-03

5.  Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report.

Authors:  Kalyan R Chitturi; Sameer Thacker; Mukhtar A Al-Saadi; Mahwash Kassi
Journal:  Eur Heart J Case Rep       Date:  2020-07-17

6.  Peripheral Thromboembolism Formation in a Case of Takotsubo Cardiomyopathy.

Authors:  Reema S Patel; Paige Webeler; Uma Mahesh Gudur
Journal:  Cureus       Date:  2022-04-12

Review 7.  Role of echocardiography for takotsubo cardiomyopathy: clinical and prognostic implications.

Authors:  Masaki Izumo; Yoshihiro J Akashi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

8.  Stress-induced cardiomyopathy (Takotsubo)--broken heart and mind?

Authors:  Björn Redfors; Yangzhen Shao; Elmir Omerovic
Journal:  Vasc Health Risk Manag       Date:  2013-04-17

9.  Recurrent Takotsubo cardiomyopathy triggered by emotionally stressful events: A case report.

Authors:  Hao-Yu Wu; Gong Cheng; Lei Liang; Yi-Wei Cao
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.